Cargando…
Hepatic Steatosis as a Marker of Metabolic Dysfunction
Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of the complex metabolic derangements associated with obesity. NAFLD is characterized by excessive deposition of fat in the liver (steatosis) and develops when hepatic fatty acid availability from plasma and de novo synthesis exceed...
Autores principales: | Fabbrini, Elisa, Magkos, Faidon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488828/ https://www.ncbi.nlm.nih.gov/pubmed/26102213 http://dx.doi.org/10.3390/nu7064995 |
Ejemplares similares
-
Markers of Glucagon Resistance Improve With Reductions in Hepatic Steatosis and Body Weight in Type 2 Diabetes
por: Kjeldsen, Sasha A S, et al.
Publicado: (2023) -
Putative Factors That May Modulate the Effect of Exercise on Liver Fat: Insights from Animal Studies
por: Magkos, Faidon
Publicado: (2012) -
Adipose tissue monomethyl branched chain fatty acids and insulin sensitivity: effects of obesity and weight loss
por: Su, Xiong, et al.
Publicado: (2014) -
Effect of weight gain and weight loss on in vivo colonocyte proliferation rate in people with obesity
por: Magkos, Faidon, et al.
Publicado: (2017) -
Fermented Foods in the Management of Obesity: Mechanisms of Action and Future Challenges
por: Jalili, Mahsa, et al.
Publicado: (2023)